Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Rectal Indomethacin vs Combination Prophylaxis for Post-ERCP Pancreatitis
NCT04425993Unknown
- Sponsor
- Air Force Medical University
- Start
- Jul 2020
- Primary completion
- May 2022
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Randomised, double-blind trial of indomethacin and isosorbide dinitrate in acute pancreatitis (AP) (4 arms), sponsored by Air Force Medical University. Primary endpoint: Rate of post-ERCP Pancreatitis at 14 days. Status: unknown.
02
Drugs
indomethacinisosorbide dinitrate
03
Conditions
acute pancreatitis (AP)
Beyond the preview
Go deeper on NCT04425993.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT04425993.